Cargando…

Humoral Immune Response after COVID-19 mRNA Vaccination in Patients with Liver Cirrhosis: A Prospective Real-Life Single Center Study

Coronavirus-disease-2019 (COVID-19) mRNA vaccination effectively reduces mortality and morbidity in cirrhotic patients, but the immunogenicity and safety of vaccination have been partially characterized. The study aimed to evaluate humoral response, predictive factors, and safety of mRNA-COVID-19 va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biliotti, Elisa, Caioli, Alessandro, Sorace, Chiara, Lionetti, Raffaella, Milozzi, Eugenia, Taibi, Chiara, Visco Comandini, Ubaldo, Maggi, Fabrizio, Puro, Vincenzo, D’Offizi, Gianpiero
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215518/ https://www.ncbi.nlm.nih.gov/pubmed/37238990 http://dx.doi.org/10.3390/biomedicines11051320

Ejemplares similares

High prevalence of asymptomatic SARS-CoV-2 infection in a cohort of liver transplant recipients in central Italy
por: Visco-Comandini, Ubaldo, et al.
Publicado: (2022)

Ultrasensitive HCV RNA Quantification in Antiviral Triple Therapy: New Insight on Viral Clearance Dynamics and Treatment Outcome Predictors
por: Garbuglia, Anna Rosa, et al.
Publicado: (2016)

Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C
por: Baiocchini, Andrea, et al.
Publicado: (2019)

Publisher Correction: Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C
por: Baiocchini, Andrea, et al.
Publicado: (2020)

Characterization of Naturally Occurring NS5A and NS5B Polymorphisms in Patients Infected with HCV Genotype 3a Treated with Direct-Acting Antiviral Agents
por: Bartolini, Barbara, et al.
Publicado: (2017)

Third dose of SARS-COV2 mRNA-vaccine in liver transplant recipients: can it bridge the response gap?
por: Montalbano, Marzia, et al.
Publicado: (2022)

Does m-RNA vaccination protect from Sars-Cov2 (asymptomatic) infection in liver transplant recipients?
por: Comandini, Ubaldo Visco, et al.
Publicado: (2022)

Phylogenetic and Phylodynamic Analysis of Delta Strains Circulating in Italy
por: Salichos, Leonidas, et al.
Publicado: (2023)

The impact of the coronavirus disease 2019 pandemic on a central Italy transplant center
por: Montalbano, Marzia, et al.
Publicado: (2020)

HCV full-length genome reconstruction with sequence independent amplification combined with next generation sequencing
por: Bartolini, Barbara, et al.
Publicado: (2012)

Hepatic Failure in COVID-19: Is Iron Overload the Dangerous Trigger?
por: Del Nonno, Franca, et al.
Publicado: (2021)

Anti-HEV IgG Avidity Testing: Utility for Diagnosing Acute and Resolved Genotype 3 Infections
por: Minosse, Claudia, et al.
Publicado: (2021)

Clinical Relevance of Torque Teno Virus (TTV) in HIV/HCV Coinfected and HCV Monoinfected Patients Treated with Direct-Acting Antiviral Therapy
por: Lapa, Daniele, et al.
Publicado: (2021)

Interferon-α Improves Phosphoantigen-Induced Vγ9Vδ2 T-Cells Interferon-γ Production during Chronic HCV Infection
por: Cimini, Eleonora, et al.
Publicado: (2012)

The Fibrosis-4 index is associated with Intensive Care Unit (ICU) admission in middle-aged patients with COVID-19
por: Biliotti, E., et al.
Publicado: (2021)

Primary and Chronic HIV Infection Differently Modulates Mucosal Vδ1 and Vδ2 T-Cells Differentiation Profile and Effector Functions
por: Cimini, Eleonora, et al.
Publicado: (2015)

Torquetenovirus Loads in Peripheral Blood Predict Both the Humoral and Cell-Mediated Responses to SARS-CoV-2 Elicited by the mRNA Vaccine in Liver Transplant Recipients
por: Minosse, Claudia, et al.
Publicado: (2023)

Analysis of HIV quasispecies and virological outcome of an HIV D+/R+ kidney–liver transplantation
por: Rozera, Gabriella, et al.
Publicado: (2022)

Phylogenetic and Phylodynamic Analyses of HCV Strains Circulating among Patients Using Injectable Drugs in Central Italy
por: Minosse, Claudia, et al.
Publicado: (2021)

Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents
por: Minosse, Claudia, et al.
Publicado: (2018)

Clinical Characteristics of Acute Hepatitis E and Their Correlation with HEV Genotype 3 Subtypes in Italy
por: Minosse, Claudia, et al.
Publicado: (2020)

Simple and Reliable Method to Quantify the Hepatitis B Viral Load and Replicative Capacity in Liver Tissue and Blood Leukocytes
por: Minosse, Claudia, et al.
Publicado: (2016)

Autophagy plays an important role in the containment of HIV-1 in nonprogressor-infected patients
por: Nardacci, Roberta, et al.
Publicado: (2014)

Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program
por: Calvaruso, Vincenza, et al.
Publicado: (2019)

High Levels of TRIM5α Are Associated with Xenophagy in HIV-1-Infected Long-Term Nonprogressors
por: Ciccosanti, Fabiola, et al.
Publicado: (2021)

Timely HAART initiation may pave the way for a better viral control
por: Paci, Paola, et al.
Publicado: (2011)

Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy
por: Paci, Paola, et al.
Publicado: (2009)

Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs
por: Minosse, Claudia, et al.
Publicado: (2021)

Elevated P-Selectin in Severe Covid-19: Considerations for Therapeutic Options
por: Agrati, Chiara, et al.
Publicado: (2021)

COVID-19 disease—Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study
por: Lanini, Simone, et al.
Publicado: (2020)

Lymphofollicular lesions associated with monkeypox (Mpox) virus proctitis
por: Mazzotta, Valentina, et al.
Publicado: (2023)

Long-Term Follow-Up of Acute Hepatitis B: New Insights in Its Natural History and Implications for Antiviral Treatment
por: Menzo, Stefano, et al.
Publicado: (2018)

National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management
por: Nicastri, Emanuele, et al.
Publicado: (2020)

Effectiveness and safety of simeprevir-based regimens for hepatitis C in Italy: The STIly observational study
por: Gaeta, Giovanni Battista, et al.
Publicado: (2018)

Coordinate Induction of Humoral and Spike Specific T-Cell Response in a Cohort of Italian Health Care Workers Receiving BNT162b2 mRNA Vaccine
por: Agrati, Chiara, et al.
Publicado: (2021)

Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation
por: Ciccosanti, Fabiola, et al.
Publicado: (2022)

ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients
por: Picchianti-Diamanti, Andrea, et al.
Publicado: (2021)

Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis
por: Keebayoon, Amnuay, et al.
Publicado: (2023)

Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study
por: Lanini, Simone, et al.
Publicado: (2018)

Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study
por: Iavarone, Massimo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kfpkfgi2qrvtkjjol760p93n5c